汇添富中证医药卫生ETF(159929)利润分配表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 收入 |
81,992,339.69 |
-253,264,798.61 |
-380,006,405.83 |
-234,444,960.42 |
| 利息合计 |
28,514.93 |
455,312.16 |
413,398.51 |
944,029.98 |
| 其中：存款利息收入 |
28,514.93 |
68,255.00 |
26,341.35 |
84,592.80 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
2,736.43 |
2,736.43 |
- |
| 投资收益合计 |
-72,632,809.78 |
-193,509,558.83 |
-80,944,126.76 |
-160,486,697.17 |
| 其中：股票投资收益 |
-93,683,975.42 |
-229,896,814.20 |
-100,581,267.13 |
-186,761,842.08 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
130,084.98 |
130,084.98 |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
21,051,165.64 |
36,257,170.39 |
19,507,055.39 |
26,275,144.91 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
155,206,299.81 |
-62,590,020.28 |
-300,063,502.82 |
-77,031,175.06 |
| 其他收入 |
-609,665.27 |
2,379,468.34 |
587,825.24 |
2,128,881.83 |
| 费用 |
6,740,101.87 |
12,044,042.36 |
5,554,917.76 |
11,549,040.27 |
| 管理人报酬 |
5,418,220.34 |
9,404,980.71 |
4,328,047.03 |
9,017,877.02 |
| 基金托管费 |
1,083,644.08 |
1,880,996.10 |
865,609.41 |
1,803,575.43 |
| 销售服务费 |
- |
- |
- |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
238,237.45 |
756,681.75 |
359,877.52 |
724,493.56 |
| 利润总额 |
75,252,237.82 |
-265,308,840.97 |
-385,561,323.59 |
-245,994,000.69 |
微信公众号
证券之星APP
基本资料
